ZAP70 and central nervous system neoplasm: Given the rarity of CNS lymphomas in ZAP70-deficient patients, further studies and case reports are needed to elucidate the association with CNS tumors, clarify underlying genetic and immunologic risk factors, and guide the development of targeted therapies.